alpha Interferon treatment of essential thrombocythaemia and other myeloproliferative disorders with excessive thrombocytosis.

The effect of recombinant interferon alfa-2b on platelet count, thrombocytosis-associated symptoms and marrow fibrosis was studied in 18 patients with myeloproliferative diseases and associated thrombocytosis (nine with essential thrombocythaemia, three with polycythaemia vera, three with myelofibrosis and three with chronic myelogenous leukaemia). A reduction of the platelet count below 600 x 10(9)/L was achieved in 94%, and below 400 x 10(9)/L in 77% of the patients within 8 to 330 days of treatment. The selective thrombocytosis-reducing effect of alpha interferon was maintained for long periods of time in most patients without serious side effects. Thrombocytosis-associated symptoms were relieved once the number of platelets was reduced to near normal levels. Marrow reticulin content was found to be reduced after treatment in two of the seven patients studied. Side effects of alpha interferon were flu-like symptoms, which usually subsided within 7 days of treatment.
AuthorsX Yataganas, J Meletis, E Plata, N Viniou, F Deligiannis, C Tsekoura, E Voscaridou, V Boussiotis, J Rombos, G Vayopoulos
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 27 Suppl 4 Pg. S69-71 ( 1991) ISSN: 0959-8049 [Print] ENGLAND
PMID1799484 (Publication Type: Journal Article)
Chemical References
  • Interferon-alpha
  • Recombinant Proteins
  • interferon alfa-2b
  • Adult
  • Aged
  • Female
  • Humans
  • Interferon-alpha (adverse effects, therapeutic use)
  • Leukocyte Count
  • Male
  • Middle Aged
  • Platelet Count
  • Recombinant Proteins
  • Thrombocythemia, Essential (therapy)
  • Thrombocytosis (therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: